Registration information requirements and risk to benefit analysis for ACVM products
Have your say
We are seeking feedback on the updated information requirements to register a product under the Agricultural Compounds and Veterinary Medicines (ACVM) Act 1997 and the risk to benefit analysis required to support such a registration. The new requirements document differs from previous ones in that it puts the focus on the applicant’s responsibility to conduct and provide a risk to benefit analysis (explained in the second document) with their registration application.
Consultation runs from 21 July 2017 to 25 August 2017.
- Registration information requirements [PDF, 463 KB]
- Risk to benefit analysis to support ACVM registration [PDF, 765 KB]
Making your submission
Email your feedback on the consultation documents by 5 pm on 25 August 2017 to ACVM.Consultation@mpi.govt.nz
Make sure you include in your submission:
- the title of the consultation document in the subject line of your email
- your name and title (if applicable)
- your organisation's name (if applicable)
- your address.
While we prefer email, you can send your submission by post to:
ACVM/ Systems Audit, Assurance and Monitoring
Ministry for Primary Industries
PO Box 2526
Submissions are public information
Any submission you make becomes public information. Anyone can ask for copies of all submissions under the Official Information Act 1982 (OIA). The OIA says we must make the information available unless we have a good reason for withholding it. You can find those grounds in sections 6 and 9 of the OIA. Tell us if you think there are grounds to withhold specific information in your submission. Reasons might include, it's commercially sensitive or it's personal information. However, any decision MPI makes to withhold information can be reviewed by the Ombudsman, who may require the information be released.
Has this been useful? Give us your feedback